Literature DB >> 9887356

Apoptosis and p53 expression in human gliomas.

L Sipos1, Z Szegedi, I Fedorcsák, D Afra, B Szende.   

Abstract

Twenty-five human gliomas of different histological grade and type were studied for p53 expression by immunohistochemistry and for apoptosis using ApopTag method. p53 expression (percentage of positive cells) was highest in anaplastic astrocytomas, followed by low grade astrocytomas and surprisingly in glioblastomas. Granular cytoplasmic p53 positivity appeared in 4/5 low grade oligodendroglioma and in 2/5 low grade mixed oligoastrocytomas. The means of apoptosis index in the different tumor types ranged between 0.8 and 11.5 with the highest values in anaplastic astrocytoma and glioblastomas. Although the number of cases per group were relatively low and the individual vales showed differences it seems that p53 expression is related to the biological aggressiveness of gliomas. It is also suggested that high level of apoptosis in malignant glioma could represent a p53 independent pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9887356     DOI: 10.1007/bf02905216

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  27 in total

1.  Characterization of human gliomas by a monoclonal antibody both on tissue culture and paraffin-embedded sections.

Authors:  L Sipos; T Wakabayashi; G T Szeifert; I Fazekas; D Afra
Journal:  Neurol Res       Date:  1992-06       Impact factor: 2.448

Review 2.  Medical treatment of high grade malignant gliomas in adults: an overview.

Authors:  A Brandes; M Soesan; M V Fiorentino
Journal:  Anticancer Res       Date:  1991 Mar-Apr       Impact factor: 2.480

3.  Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

Authors:  P Shaw; R Bovey; S Tardy; R Sahli; B Sordat; J Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

4.  Clinical application of monoclonal antibodies against glioma-associated antigens.

Authors:  J Yoshida; T Wakabayashi; A Kito; N Kageyama; Y Murata; H Seo; N Kojima; K Yagi
Journal:  Prog Exp Tumor Res       Date:  1987

5.  Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma.

Authors:  T Wakabayashi; J Yoshida; H Seo; K Kazo; Y Murata; N Matsui; N Kageyama
Journal:  J Neurosurg       Date:  1988-03       Impact factor: 5.115

6.  Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas.

Authors:  T J Hegarty; A F Thornton; R F Diaz; W F Chandler; W D Ensminger; L Junck; M A Page; S S Gebarski; T W Hood; P L Stetson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-08       Impact factor: 7.038

7.  Treatment and survival of low-grade astrocytoma in adults--1977-1988.

Authors:  B M McCormack; D C Miller; G N Budzilovich; G J Voorhees; J Ransohoff
Journal:  Neurosurgery       Date:  1992-10       Impact factor: 4.654

8.  Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas.

Authors:  D Afra; B Kocsis; S Kerpel-Fronius; S Eckhardt
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

Review 9.  Genetics of the malignant progression of astrocytoma.

Authors:  T Mikkelsen; J G Cairncross; W K Cavenee
Journal:  J Cell Biochem       Date:  1991-05       Impact factor: 4.429

10.  Clonal expansion of p53 mutant cells is associated with brain tumour progression.

Authors:  D Sidransky; T Mikkelsen; K Schwechheimer; M L Rosenblum; W Cavanee; B Vogelstein
Journal:  Nature       Date:  1992-02-27       Impact factor: 49.962

View more
  3 in total

1.  Expression of p57(KIP2) potently blocks the growth of human astrocytomas and induces cell senescence.

Authors:  A Tsugu; K Sakai; P B Dirks; S Jung; R Weksberg; Y L Fei; S Mondal; S Ivanchuk; C Ackerley; P A Hamel; J T Rutka
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Transformed Root Extract of Leonurus sibiricus Induces Apoptosis through Intrinsic and Extrinsic Pathways in Various Grades of Human Glioma Cells.

Authors:  Przemysław Sitarek; Ewa Skała; Monika Toma; Marzena Wielanek; Janusz Szemraj; Tomasz Skorski; Adam J Białas; Tomasz Sakowicz; Tomasz Kowalczyk; Maciej Radek; Halina Wysokińska; Tomasz Śliwiński
Journal:  Pathol Oncol Res       Date:  2016-12-28       Impact factor: 3.201

3.  Glioma Association and Balancing Selection of ZFPM2.

Authors:  Shui-Ying Tsang; Lingling Mei; Weiqing Wan; Jun Li; Yi Li; Cunyou Zhao; Xiaofan Ding; Frank W Pun; Xiaoxia Hu; Jianmin Wang; Junyi Zhang; Rongcheng Luo; Siu-Tim Cheung; Gilberto K K Leung; Wai-Sang Poon; Ho-Keung Ng; Liwei Zhang; Hong Xue
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.